Study finds increase in drug-resistant A. baumannii infections
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections between 2018 to 2022. A. baumannii is a pathogen considered to be a major cause of health care-associated infections. The study found that A. baumannii cases per 100 hospitalization encounters grew from 1.15 in 2018 to 1.25 in 2021, before dropping to 1.11 in 2022. The CRAB incidence rate grew from 0.39 cases per 100 hospitalization encounters in 2018 to 0.53 cases in 2022.
Researchers said the pathogen’s ability to survive in hospitals and in patients not showing any symptoms for extended periods of time contributed to increased outbreaks.
Related News Articles
Headline
The Pennsylvania Department of Health announced Oct. 5 that the state has reached 1,004 confirmed measles cases this year. There have been 27 new positive…
Headline
A fifth measles-associated death was recorded in Pennsylvania, the state’s Department of Health announced Sept. 30. The department said the individual was…
Headline
The Pennsylvania Department of Health Sept. 15 announced the confirmation of two additional measles-associated deaths, bringing the state’s total to four. The…
Headline
A multistate cyclospora outbreak linked to iceberg lettuce has been declared over, the Centers for Disease Control and Prevention and Food and Drug…
Headline
Two individuals in Pennsylvania have died from measles, the Pennsylvania Department of Health announced Aug. 25. They are the first deaths from the disease in…
Headline
President Trump signed an executive order Aug. 10 revamping the federal government’s recommended childhood vaccine schedule. The order divides immunizations…